| pubmed-article:18787359 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18787359 | lifeskim:mentions | umls-concept:C0599755 | lld:lifeskim |
| pubmed-article:18787359 | lifeskim:mentions | umls-concept:C0750484 | lld:lifeskim |
| pubmed-article:18787359 | lifeskim:mentions | umls-concept:C0596545 | lld:lifeskim |
| pubmed-article:18787359 | lifeskim:mentions | umls-concept:C0681842 | lld:lifeskim |
| pubmed-article:18787359 | lifeskim:mentions | umls-concept:C1548161 | lld:lifeskim |
| pubmed-article:18787359 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:18787359 | pubmed:dateCreated | 2008-10-14 | lld:pubmed |
| pubmed-article:18787359 | pubmed:abstractText | Cannabis use has been identified as a possible risk factor for developing schizophrenia. In a previous paper we reported preliminary evidence that cannabis use increases the likelihood of psychosis-like experiences in non-clinical respondents who scored highly on a measure of schizotypy. We now present findings from pooled data from 3 new follow-up studies comprising a sample of 477 respondents, of whom 332 reported using cannabis at least once. | lld:pubmed |
| pubmed-article:18787359 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18787359 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18787359 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:18787359 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18787359 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18787359 | pubmed:issn | 1423-033X | lld:pubmed |
| pubmed-article:18787359 | pubmed:author | pubmed-author:LewisSS | lld:pubmed |
| pubmed-article:18787359 | pubmed:author | pubmed-author:StirlingJJ | lld:pubmed |
| pubmed-article:18787359 | pubmed:author | pubmed-author:RoemerGG | lld:pubmed |
| pubmed-article:18787359 | pubmed:author | pubmed-author:IrshadSS | lld:pubmed |
| pubmed-article:18787359 | pubmed:author | pubmed-author:BarkusE JEJ | lld:pubmed |
| pubmed-article:18787359 | pubmed:author | pubmed-author:NabosiLL | lld:pubmed |
| pubmed-article:18787359 | pubmed:author | pubmed-author:Schreudergoid... | lld:pubmed |
| pubmed-article:18787359 | pubmed:copyrightInfo | (c) 2008 S. Karger AG, Basel. | lld:pubmed |
| pubmed-article:18787359 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:18787359 | pubmed:volume | 41 | lld:pubmed |
| pubmed-article:18787359 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18787359 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18787359 | pubmed:pagination | 371-8 | lld:pubmed |
| pubmed-article:18787359 | pubmed:meshHeading | pubmed-meshheading:18787359... | lld:pubmed |
| pubmed-article:18787359 | pubmed:meshHeading | pubmed-meshheading:18787359... | lld:pubmed |
| pubmed-article:18787359 | pubmed:meshHeading | pubmed-meshheading:18787359... | lld:pubmed |
| pubmed-article:18787359 | pubmed:meshHeading | pubmed-meshheading:18787359... | lld:pubmed |
| pubmed-article:18787359 | pubmed:meshHeading | pubmed-meshheading:18787359... | lld:pubmed |
| pubmed-article:18787359 | pubmed:meshHeading | pubmed-meshheading:18787359... | lld:pubmed |
| pubmed-article:18787359 | pubmed:meshHeading | pubmed-meshheading:18787359... | lld:pubmed |
| pubmed-article:18787359 | pubmed:meshHeading | pubmed-meshheading:18787359... | lld:pubmed |
| pubmed-article:18787359 | pubmed:meshHeading | pubmed-meshheading:18787359... | lld:pubmed |
| pubmed-article:18787359 | pubmed:meshHeading | pubmed-meshheading:18787359... | lld:pubmed |
| pubmed-article:18787359 | pubmed:meshHeading | pubmed-meshheading:18787359... | lld:pubmed |
| pubmed-article:18787359 | pubmed:meshHeading | pubmed-meshheading:18787359... | lld:pubmed |
| pubmed-article:18787359 | pubmed:meshHeading | pubmed-meshheading:18787359... | lld:pubmed |
| pubmed-article:18787359 | pubmed:meshHeading | pubmed-meshheading:18787359... | lld:pubmed |
| pubmed-article:18787359 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:18787359 | pubmed:articleTitle | Cannabis-induced psychotic-like experiences are predicted by high schizotypy. Confirmation of preliminary results in a large cohort. | lld:pubmed |
| pubmed-article:18787359 | pubmed:affiliation | Department of Psychology and Speech Pathology, Manchester Metropolitan University, Manchester, UK. j.stirling@mmu.ac.uk | lld:pubmed |
| pubmed-article:18787359 | pubmed:publicationType | Journal Article | lld:pubmed |
